Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study by unknown
1 3
Arch Toxicol (2016) 90:137–148
DOI 10.1007/s00204-014-1392-6
TOXICOKINETICS AND METABOLISM
Bioactivation of food genotoxicants 5‑hydroxymethylfurfural 
and furfuryl alcohol by sulfotransferases from human, mouse 
and rat: a comparative study
Benjamin Sachse · Walter Meinl · Yasmin Sommer · 
Hansruedi Glatt · Albrecht Seidel · 
Bernhard H. Monien 
Received: 14 July 2014 / Accepted: 16 October 2014 / Published online: 5 November 2014 
© The Author(s) 2014. This article is published with open access at Springerlink.com
nucleophilic scavenger for the reactive 2-sulfoxymethylfuran 
(t1/2 = 20 s at 37 °C). The resulting adduct N6-((furan-2-yl)
methyl)-adenosine (N6-MF-A) was quantified by isotope-
dilution UPLC-MS/MS. The rates of N6-MF-A formation 
showed that hSULT1A1 and its orthologues in mice and rats 
were also the most important contributors to FFA sulfocon-
jugation in each of the species. Taken together, the catalytic 
capacity of hSULT1A1 is comparable to that of mSult1a1 
in mice, the species in which carcinogenic effects of HMF 
and FFA were detected. This is of primary concern due to the 
expression of hSULT1A1 in many different tissues.
Keywords Food carcinogens · 5-Hydroxymethylfurfural · 
Furfuryl alcohol · Sulfotransferase · UPLC-MS/MS
Introduction
5-Hydroxymethylfurfural (HMF) and furfuryl alcohol 
(FFA) are furan derivatives present in many foodstuffs. 
HMF is formed from reducing sugars in the Maillard 
Abstract 5-Hydroxymethylfurfural (HMF) and furfuryl 
alcohol (FFA) are moderately potent rodent carcinogens 
that are present in thermally processed foodstuffs. The car-
cinogenic effects were hypothesized to originate from sul-
fotransferase (SULT)-mediated bioactivation yielding DNA-
reactive and mutagenic sulfate esters, a confirmed metabolic 
pathway of HMF and FFA in mice. It is known that ortholo-
gous SULT forms substantially differ in substrate specific-
ity and tissue distribution. This could influence HMF- and 
FFA-induced carcinogenic effects. Here, we studied HMF 
and FFA sulfoconjugation by 30 individual SULT forms of 
humans, mice and rats. The catalytic efficiencies (kcat/KM) of 
HMF sulfoconjugation of human SULT1A1 (13.7 s−1 M−1), 
mouse Sult1a1 (15.8 s−1 M−1) and 1d1 (4.8 s−1 M−1) and 
rat Sult1a1 (5.3 s−1 M−1) were considerably higher than 
those of all other SULT forms investigated (≤0.73 s−1 M−1). 
FFA sulfoconjugation was monitored using adenosine as a 
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reaction and by acid-catalyzed dehydration. It occurs in 
carbohydrate-rich foods (Husoy et al. 2008; Murkovic and 
Swasti 2013), coffee, fruit juices and other beverage prod-
ucts (Murkovic and Pichler 2006; Teixido et al. 2006) and 
cigarette smoke (Crump and Gardner 1989). Estimates of 
the mean daily dietary intake are in the range of 4–30 mg 
HMF per person (Federal Institute of Risk Assessment 
(BfR) 2011). The structural congener FFA originates 
from cyclization and aromatization of 2-deoxypentose, a 
key intermediate of heat-induced degradation of glucose 
or fructose (Brands and van Boekel 2001). It is found in 
thermally processed foods such as cocoa, tea, coffee, dehy-
drated orange products, cooked meat and milk products 
(Maga 1979; Murkovic and Swasti 2013). High concen-
trations of FFA in coffee (267–1,490 µg/g in three differ-
ent brands) result in intake amounts of several mg FFA 
per serving (Murkovic and Swasti 2013). Humans are also 
exposed by inhalation, particularly in occupational environ-
ments due to FFA use in the manufacturing of furan resins 
(Ahman et al. 1991), but also in residencies, where high 
levels of FFA (0.4–500 µg/g dust) were found in particulate 
matter (Nilsson et al. 2005).
HMF and FFA are rodent carcinogens. It was reported 
that HMF caused the formation of aberrant crypt foci in the 
colon of rats (Zhang et al. 1993) and neonatal Min/+ mice 
(Svendsen et al. 2009) and initiated papillomas in mouse 
skin (Surh et al. 1994). Oral administration of 188 mg 
HMF/kg for 104 weeks led to increased incidences of hepa-
tocellular adenomas in female B6C3F1 mice compared 
with the control animals (National Toxicology Program 
2008). The exposure of male B6C3F1 mice to 32 ppm FFA 
in the air (equivalent to 60 mg FFA/kg bw/day) induced 
renal tubule neoplasms, which were also observed in some 
of the female rats (National Toxicology Program 1999). 
The mutagenic potential of HMF (Glatt et al. 2005; Jan-
zowski et al. 2000; National Toxicology Program 2008) 
and FFA (Aeschbacher et al. 1989; National Toxicology 
Program 1999) was small in standard in vitro tests. How-
ever, the mutagenic and genotoxic activity observed in 
sulfotransferase (SULT)-proficient bacteria (Glatt et al. 
2011) and mammalian cell lines suggests that the tumor-
initiating potential of HMF and FFA may depend, in part or 
completely, on sulfoconjugation. This hypothesis was lend 
further credibility by a toxicokinetic study demonstrating 
that HMF is converted into mutagenic 5-sulfoxymethylfur-
fural (SMF) in FVB/N mice (Monien et al. 2009) and that 
2-methylfuran adducts such as N2-((furan-2-yl)methyl)-2′-
deoxyguanosine were detected in DNA from liver, kidney 
and lung of FVB/N mice that received FFA in the drinking 
water over 4 weeks (Monien et al. 2011).
It is disturbing that the margins between the carcino-
genic doses found in animal experiments and the estimated 
mean intake values for HMF and FFA are relatively small. 
The dose of 188 mg HMF/kg body weight significantly 
increased the incidence of liver adenoma in female mice 
in a two-year bioassay. This is merely 440- to 3,300-fold 
higher compared with the human HMF uptake {calcu-
lated with 70 kg human body weight and the HMF uptake 
range of 4–30 mg per person given by the German Federal 
Institute of Risk Assessment (BfR)] (Federal Institute of 
Risk Assessment (BfR) 2011; National Toxicology Pro-
gram 2008). The European Food Safety Authority (EFSA) 
stated that a margin of exposure below 10,000 indicates a 
high priority for risk assessment, if the carcinogenicity was 
based on a genotoxic mechanism (European Food Safety 
Authority 2005). Moreover, due to considerable differences 
in SULT expression and substrate specificities of ortholo-
gous SULT forms between species (Glatt 2002), human 
sensitivity to HMF- and FFA-induced effects may differ 
from that of rodents. Here, we present a comprehensive 
overview about sulfoconjugation of HMF and FFA by indi-
vidual SULTs of human and rodent origin using cytosolic 




FFA was purchased from Merck Schuchardt (Hohenb-
runn, Germany). HMF, adenosine, ammonium bicarbo-
nate and all other reagents (analytical grade) were from 
Sigma-Aldrich (Taufkirchen, Germany). HPLC-grade 
methanol, 2-propanol and formic acid were from Carl 
Roth GmbH (Karlsruhe, Germany), and HPLC-grade 
water was prepared using a Milli-Q Integral Water Purifi-
cation System (Millipore Merck, Darmstadt, Germany). 
Stable isotope-labeled [15N5]adenosine was from Silantes 
GmbH (Munich, Germany). Sulfation reactions of HMF 
and FFA yielding SMF (Monien et al. 2009) and 2-sulfoxy-
methylfuran (Monien et al. 2011), respectively, were con-
ducted as described. The cofactor 3′-phosphoadenosine-5′-
phosphosulfate (PAPS) was prepared using human PAPS 
synthetase 2 expressed in Escherichia coli and was purified 
using anion-exchange chromatography (purity > 99.0 %) 
(Muckel et al. 2001).





The ribonucleoside adduct of FFA was prepared by dis-
solving 100 mg adenosine (374 µmol) in 50 ml sodium 
phosphate buffer (pH 8.0) together with 80 mg (400 µmol) 
of freshly prepared 2-sulfoxymethylfuran (Monien et al. 
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2011). The solution was stirred for 15 min at 37 °C. The 
product mixture was subjected to HPLC purification using 
a Prep LC 150 (Waters, Eschborn, Germany) coupled to a 
PDA detector 996 (Waters) and a preparative column Sun-
Fire C18 OBD (5 µm, Waters). The product was eluted with 
5 % methanol (solvent A) and 75 % methanol (solvent B) 
using a linear gradient from 100 % solvent A to 10 % sol-
vent A in 20 min at a flow rate of 20 ml/min. The prod-
uct containing fractions were pooled and freeze-dried. The 
purity of the product was >99 % as determined by UPLC-
UV-MS/MS (MS (ESI+) m/z = 348.1 [M + H]+). 1H-NMR 
of N6-MF-A (300 MHz, dimethyl sulfoxide-d6) δ [ppm]: 
8,40 (s, 1H, H8), 8,26 (bs, 1H, N-H), 8,15 (s, 1H, H2); 7,55 
(s, 1H, H5″), 6,37–6,38 (d, 1H, H1′), 6,24–6,25 (d, 1H, 
H4″), 5,90–5,91 (d, 1H, H3″), 5,49–5,50 (m, 1H, O-H2′), 
5,42–5,44 (m, 1H, O-H5′), 5,24 (m, 1H, O-H3′), 4,62–4,63 
(m, 2H, N-CH2); 4,60–4,61 (m, 1H, H3′), 4,15–4,16 (m, 
1H, H2′), 3,97–3,98 (m, 1H, H4′), 3,74–3,75 (m, 1H, H5′), 
3,67–3,69 (m, 1H, H5′2). The stable isotope-labeled sub-
stance [15N5]N
6-MF-A was prepared in the same manner 
downscaling the reaction by factor 50.
Cytosolic preparations of SULT-expressing S. typhimurium 
TA1538
Cytosolic fractions containing individual SULT forms were 
prepared from transgenic S. typhimurium TA1538. Table S1 
in the Supplementary Material provides a summary of the 
thirty SULTs used in the current study together with refer-
ences describing the cloning of the respective S. typhimurium 
TA1538 strains. The expressed SULT forms are denoted 
with the prefixes h, m and r for human, mouse and rat 
enzymes, respectively. Bacteria were grown in Luria Broth 
medium containing ampicillin (100 µg/ml) by stirring for 8 h 
at 200 revolutions/min at 37 °C. The bacterial suspensions 
were centrifuged at 5,000 g for 10 min. The sediments were 
washed twice with 25 ml of 10 mM potassium phosphate 
buffer (pH 7.4)/50 mM potassium chloride (KCP buffer) 
and centrifuged again. The pellets were taken up in 800 µl 
KCP buffer and sonicated thrice for 15 s with 30 s pauses 
in between. The soluble fraction was attained by centrifug-
ing for 1 h at 100,000 g. The supernatants (in the following 
termed cytosolic preparations) were frozen at −80 °C. The 
protein concentrations were determined according to a bicin-
choninic acid (BCA) assay protocol. The SULT concentra-
tions in the cytosolic preparations were estimated after elec-
trophoretic separation and immunodetection using inclusion 
bodies of different SULT forms as standards (Teubner et al. 
2007). The preparation of SULT inclusion bodies and the 
immunodetection of SULTs is described in the Supplemen-
tary Material, which also contains a representative immuno-
blot of different amounts of rSult1a1standard and a cytosolic 
preparation of S. typhimurium expressing rSult1a1 (Fig. S1).
HMF sulfoconjugation assay
The reactions were conducted in mixtures of 100 µl con-
taining 25–200 µg protein, 50 mM potassium phosphate 
buffer (pH 7.4), 5 mM MgCl2, 50 µM PAPS and differ-
ent concentrations of HMF at 37 °C. Preliminary experi-
ments ensured that measurements were recorded under 
‘linear’ conditions, i.e., doubling of protein concentration 
or incubation time was doubling the amount of sulfate ester 
formed. The reactions were stopped after 30 min by add-
ing 300 µl ice-cold 2-propanol, mixed and centrifuged at 
15,000 g for 10 min.
SMF concentrations of the clear supernatants were ana-
lyzed by UPLC-MS/MS. The protocol was adapted from 
the quantification of SMF in plasma samples of HMF-
treated mice (Monien et al. 2009). In short, the superna-
tants were analyzed using a UPLC system (Waters) con-
nected to a Quattro Premier XE tandem quadrupole mass 
spectrometer (Waters) using the negative electrospray 
ionization mode. Samples of 4 µl were injected into a HSS 
T3 column (1.8 µm, 2.1 × 100 mm; Waters) and eluted 
with an isocratic flow of 0.35 ml/min 10 mM ammonium 
acetate/methanol (95:5). The fragmentation reactions of 
SMF yielding two principal ions, the sulfate ion radical 
(m/z = 204.9 → 96.0) and the protonated sulfonate ion 
(m/z = 204.9 → 81.0) were monitored. The tune param-
eters were as follows: temperature of the electrospray 
source 120 °C; desolvation temperature 475 °C; desolva-
tion gas nitrogen (800 l/h); cone gas nitrogen (100 l/h); col-
lision gas argon (indicated cell pressure ~5 × 10−3 mbar). 
For the fragmentation of SMF, collision energies were 20 
and 23 eV for the transitions m/z = 204.9 → 81.0 and 
m/z = 204.9 → 96.0, respectively. The dwell time was set 
to 100 ms, and capillary voltage was set to 0.35 kV. The 
cone and RF1 lens voltages were 32 and 0.2 V, respectively. 
SMF was quantified using an external calibration line that 
was linear in the concentration range of 1.0 nM (4 fmol/
injection) to 2,500 (10 pmol/injection) SMF (r2 ≥ 0.99). 
Data acquisition and handling were performed with Mass-
Lynx 4.1 software (Waters). The limit of detection (LOD) 
for this technique of 2.5 nM SMF has been reported (Mon-
ien et al. 2009). In the current study, this corresponds to 
10 fmol SMF per injection or a reaction rate of 0.5 pmol 
SMF/mg/min.
FFA sulfoconjugation assay
The reaction mixtures were prepared as described for HMF. 
In addition, they contained 10 mM adenosine as a nucleo-
philic scavenger. Following incubation for 20 min at 37 °C, 
sulfoconjugation reactions were stopped by adding 100 µl 
cold methanol containing 175 fmol of [15N5]N
6-MF-A as 
the internal standard, mixed and centrifuged at 15,000 g 
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for 10 min. The clear supernatants were subjected to 
UPLC-MS/MS analyses. Incubations were performed as 
quadruplicates. At higher concentrations, FFA reacts spon-
taneously with adenosine at low, but detectable, levels. 
To correct for the SULT-independent adduct formation, 
mixtures with SULT-deficient cytosols were carried along 
simultaneously in duplicate. Controls were subtracted from 
the experimental samples.
The ribonucleoside adduct N6-((furan-2-yl)methyl)-
adenosine (N6-MF-A) was analyzed by isotope-dilution 
UPLC-MS/MS with the same system described above 
using a HSS T3 column (1.8 µm, 2.1 × 100 mm, Waters). 
Samples of 8 µl were eluted with 10 mM ammonium 
bicarbonate buffer, pH 8.0 (A) and methanol (B) using an 
6-min gradient from 98 % solvent A to 15 % solvent A at 
0.35 ml/min flow rate (Yin et al. 2013). The electrospray 
interface of the mass spectrometer operated in the posi-
tive ion mode. The fragmentations of N6-MF-A into the 
aglycone cation [N6-((furan-2-yl)methyl)-adenine-H]+ 
(m/z = 348.1 → 216.1), the cleavage of the 2-methylfuranyl 
cation (m/z = 348.1 → 81.0) and the release of [N6-methyl-
adenine-H]+ (m/z = 348.1 → 148.0) were monitored 
together with the corresponding fragmentations of the iso-
tope-labeled internal standard [15N5]N
6-MF-A for the for-
mation of the aglycone (m/z = 353.1 → 221.1), the 2-meth-
ylfuran cation (m/z = 353.1 → 81.0) and 15N5-labeled 
N6-methyl-adenine (m/z = 353.1 → 153.0). The N6-MF-A 
content of the incubation mixture was calculated from the 
ratio of peak areas resulting from the total ion current of 
all three MRM signals of the analyte. For the fragmenta-
tion of N6-MF-A ([15N5]N
6-MF-A), collision energies were 
20, 25 and 35 eV for the transitions m/z = 348.1 → 216.1 
(m/z = 353.1 → 221.1), m/z = 348.1 → 148.0 
(m/z = 353.1 → 153.0) and m/z = 348.1 → 81.0 
(m/z = 353.1 → 81.0), respectively. The tune parameters 
were as follows: temperature of the electrospray source 
110 °C; desolvation temperature 450 °C; desolvation gas 
nitrogen (850 l/h); cone gas nitrogen (50 l/h); collision gas 
argon (indicated cell pressure ~5 × 10−3 mbar). The dwell 
time was set to 100 ms. The cone gas voltage and capillary 
voltage were set to 25 V and 0.7 kV, respectively. The RF1 
lens voltage was 0.1 V. Data acquisition and handling were 
performed with MassLynx 4.1 software (Waters).
The trace amounts of N6-MF-A also formed in the 
absence of SULTs increased with increasing concentrations 
of FFA in the incubation mixture. Due to this background, 
the LOD values for the quantification of N6-MF-A were 
determined individually for each of the FFA concentrations 
from the background integral of the total ion current from 
all three transitions of N6-MF-A monitored at the precise 
retention time in incubations containing all components 
and SULT-deficient cytosol from S. typhimurium. Only a 
concentration of N6-MF-A exceeding the arithmetic mean 
area of the daily background signal from 10 to 12 blank 
incubations by more than twofold was considered to be 
above the LOD. The resulting LOD values for incubations 
with 0.1, 1 and 10 mM FFA were 0.18, 0.20 and 0.44 nM 
N6-MF-A, respectively, corresponding to reaction rates of 
18, 20 and 44 fmol N6-MF-A/mg/min.
Results
Quantification of SMF by UPLC-MS/MS
The analytical technique used in this study was adapted 
from the SMF quantification in plasma samples of HMF-
treated mice (Monien et al. 2009). This is beset with two 
potential sources of inaccuracy. First, SMF is a reactive ana-
lyte with half-life times of 114, 126 and 108 min in water, 
urine and plasma, respectively, at 37 °C (Monien et al. 
2009). Here, we chose a reaction time of 30 min. Assuming 
a continuous linear formation of SMF during the incubation 
and a half-life of 120 min, about 6 % of newly formed SMF 
should degrade before stopping the reaction by adding cold 
2-propanol. Notably, SMF was more stable in solutions con-
taining 75 % 2-propanol at 4 °C without any detectable deg-
radation within four weeks. SMF was analyzed by UPLC-
MS/MS in the MRM mode using the specific fragmentation 
reactions of the sulfate ion radical (m/z = 204.9 → 96.0) 
and the protonated sulfonate ion (m/z = 204.9 → 81.0) 
(Monien et al. 2009). Representative chromatograms are 
shown in Fig. S2 of the Supplementary Material. The SMF 
levels resulting from HMF sulfoconjugation were quantified 
using SMF solutions at various concentrations as external 
calibration line prepared in water/2-propanol (1:3), which 
represents the solvent composition in the incubation mixture 
following instant stopping and precipitating of proteins. The 
second source of imprecision of mass spectrometric SMF 
quantification with an external calibration is the possible 
ion suppression by residues from bacterial cytosol or buffer 
salts in the samples. This was tested in a separate experi-
ment measuring the peak areas of six series of solutions 
with five different SMF concentrations, either prepared with 
water or with the contents of the incubation mixture includ-
ing 1 mg/ml protein from a cytosolic preparation of native 
S. typhimurium TA1538. The results, summarized in Table 
S2 of the Supplementary Material, showed that ion suppres-
sion did not interfere with SMF detection.
Sulfoconjugation of HMF by individual human, mouse 
and rat SULTs
HMF sulfoconjugation was assessed in cytosolic prepa-
rations from various strains of S. typhimurium TA1538 
expressing individual SULT forms of human, mouse and 
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rat. This allowed including 30 SULT forms in this study 
without time-consuming, multi-step chromatographic pro-
cedures for the purification of individual enzymes. The 
approach offers two additional advantages. First, we found 
that SULTs in cytosolic preparations are more stable com-
pared with purified enzymes (Teubner et al. 2007), and, sec-
ond, consumed cofactor 3′-phosphoadenosine-5′-phosphate 
(PAP) acts as a SULT inhibitor in assays with purified 
enzymes, but is rapidly decomposed in cytosolic bacte-
rial preparations. Sulfoconjugation of all 30 SULT forms 
was assessed using 0.1, 1, 10 and 100 mM HMF (Table 1). 
Among twelve human SULTs included in the study, nine 
enzymes were found to catalyze HMF conjugation with 
highest rates observed for SULT1A1, 1A2, 1A3, 1B1 and 
1C2. From seven mouse Sult forms catalyzing HMF sul-
foconjugation mSult1a1, 1d1 and 1e1 stood out due to the 
highest turnover rates. Generally, rat Sults showed low 
activity toward HMF, the highest activity being found for 
rSult1c1.
Eleven of the most active SULTs, five human, three 
mouse and three rat enzymes, were subjected to a com-
prehensive kinetic investigation (compare Table 2). The 
selection was based on the HMF sulfoconjugation rate 
(Table 1), but also on the quantitative importance of indi-
vidual SULTs, determined by the tissue distribution in a 
given adult species and the expression levels reported in 
Table 1  Rates of sulfoconjugation assayed at four HMF concentrations in cytosolic preparations of S. typhimurium TA1538 containing different 
SULT forms from human, mouse and rat
Values are mean ± SE of three or four measurements. The limit of detection (signal-to-noise ratio = 4) was 2.5 nM SMF or 10 fmol SMF on 
column corresponding to a rate of 0.5 pmol/mg/min under the assay conditions used (Monien et al. 2009)
Species SULT Rate (pmol/mg/min)
0.1 mM HMF 1 mM HMF 10 mM HMF 100 mM HMF
Human 1A1 20.4 ± 2.8 171 ± 18 641 ± 100 699 ± 170
1A2 <0.5 15.2 ± 4.5 130 ± 53 628 ± 233
1A3 1.2 ± 0.1 12.1 ± 1.5 117 ± 12 406 ± 39
1B1 2.0 ± 0.5 22.2 ± 5.2 133 ± 28 272 ± 49
1C1 <0.5 <0.5 4.7 ± 0.3 11.0 ± 1.4
1C2 1.1 ± 0.3 14.0 ± 1.8 115 ± 14 285 ± 71
1C3 <0.5 1.0 ± 0.1 7.2 ± 0.9 3.6 ± 0.2
1E1 <0.5 1.0 ± 0.2 5.7 ± 0.8 7.7 ± 1.2
2A1 <0.5 2.4 ± 0.6 31.1 ± 5.4 201 ± 39
2B1a <0.5 <0.5 <0.5 <0.5
2B1b <0.5 <0.5 <0.5 <0.5
4A1 <0.5 <0.5 <0.5 <0.5
Mouse 1a1 76.6 ± 14.4 722 ± 93 2,010 ± 210 1,970 ± 70
1b1 0.9 ± 0.1 8.2 ± 0.1 66.2 ± 6.8 64.4 ± 5.0
1c2 <0.5 2.0 ± 0.2 16.2 ± 1.1 92.4 ± 6.7
1d1 124 ± 33 1,160 ± 260 6,750 ± 1,190 22,400 ± 2,400
1e1 3.7 ± 0.3 35.5 ± 2.6 226 ± 9 534 ± 52
2a1 <0.5 1.3 ± 0.2 9.0 ± 0.9 13.1 ± 1.7
2a2 <0.5 4.4 ± 0.8 32.4 ± 3.2 77.5 ± 11.7
2a3 <0.5 <0.5 <0.5 <0.5
2b1b <0.5 <0.5 <0.5 <0.5
5a1 <0.5 <0.5 <0.5 <0.5
Rat 1a1 <0.5 6.5 ± 2.1 43.6 ± 13.7 36.1 ± 16.8
1b1 <0.5 3.4 ± 0.2 25.2 ± 0.4 30.8 ± 1.2
1c1 2.1 ± 1.3 29.1 ± 9.0 120 ± 39 47.5 ± 27.3
1c2 <0.5 <0.5 2.3 ± 0.2 15.0 ± 1.1
2a1 <0.5 1.8 ± 0.1 17.2 ± 0.6 58.9 ± 4.6
2a3 0.6 ± 0.0 6.2 ± 0.2 62.8 ± 4.6 76.5 ± 8.8
2a4 <0.5 <0.5 <0.5 <0.5
2b1 <0.5 <0.5 <0.5 <0.5
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relevant organ tissues, especially liver, kidney and colon 
(Glatt 2002; Riches et al. 2009; Teubner et al. 2002). Cur-
rent knowledge of these parameters will be discussed. Sul-
foconjugation rates of selected enzymes were monitored 
at ten HMF concentrations. The resulting data were fitted 
to the Michaelis–Menten equation yielding the Michaelis–
Menten constant (KM) and the maximum rate (VMAX,cyt). It 
is of note that VMAX,cyt was based on the total protein con-
tent in the cytosolic preparations. Figure 1 shows represent-
ative kinetics of HMF sulfoconjugation with hSULT1A1, 
mSult1a1 and rSult1a1 with KM values of 3.2 ± 0.4, 
2.0 ± 0.3 and 4.9 ± 0.7 mM, respectively. The values of the 
catalytic parameters KM and VMAX,cyt of all selected SULT 
forms are summarized in Table 2. The sulfoconjugation by 
rSult1c1 was notable due to a decrease in the rate observed 
at concentrations higher than 50 mM HMF (Supplemen-
tary Material Fig. S3). Assuming a substrate inhibitory 
effect, KM and VMAX,cyt were derived from the extended 
Michaelis–Menten equation V = VMAX,cyt/(1 + KM/
[HMF] + [HMF]/KI)that also allowed estimating the dis-
sociation constant (KI) of the complex formed by rSult1c1-
HMF and a second HMF molecule (KI = 13.2 ± 3.4 mM).
Fitting of HMF sulfoconjugation rates yielded values of 
apparent VMAX,cyt related to the overall protein content of 
the cytosolic preparations. In order to correct the VMAX,cyt, 
we determined the actual SULT levels of the cytosolic 
preparations containing the most effective enzymes by 
immunoblotting using inclusion bodies of homogenous 
SULTs as reference proteins. Usually, cytosolic SULT con-
centrations were in the range of those reported previously 
(Meinl et al. 2006, 2013). The actual reaction rates VMAX 
calculated from VMAX,cyt and the SULT content of individ-
ual cytosolic preparations are included in Table 2.
The KM values of HMF turnover observed for SULT1A1 
forms of all three species and rSult1c1 were markedly 
lower compared with those of all other SULT forms stud-
ied. The reaction rates VMAX were relatively high with 
values of 77.8, 55.9 and 45.8 nmol/mg/min for SULT1A1 
from human, mouse and rat, respectively. Similar or higher 
rates were only found for hSULT1A2 (71.3 nmol/mg/min) 
and mSult1d1 (273 nmol/mg/min). However, the high 
activities of these enzymes were associated with high KM 
values. The calculation of kcat/KM as a measure for the cata-
lytic efficiency of HMF sulfoconjugation confirmed the 
predominant role of SULT1A1 in all three species with cat-
alytic efficiencies of 13.7, 15.8 and 5.3 s−1 M−1 for human, 
mouse and rat SULT1A1, respectively.
Quantification of N6-((furan-2-yl)methyl)-adenosine 
(N6-MF-A) by UPLC-MS/MS
The protocol of HMF sulfoconjugation by individual SULTs 
was modified for FFA, because the reactivity of 2-sulfoxym-
ethylfuran (t1/2 = 20 s in water at 37 °C, (Glatt et al. 2012)) 
Table 2  Kinetic parameters of HMF sulfoconjugation catalyzed by most prominent SULT forms from human, mouse and rata
a Values of KM and VMAX,cyt (±SE) were determined by fitting the HMF sulfoconjugation data averaged from three to five measurements con-
ducted on different occasions with the Michaelis–Menten equation (compare Fig. 1)
b Values of VMAX,cyt were calculated from whole protein concentrations in the cytosolic preparations
c VMAX was calculated from VMAX,cyt by correction with the concentrations of individual SULT forms in the cytosolic preparations. These were 
determined by immunoblotting and comparison with various amounts of inclusion bodies containing >99 % SULT as described by Meinl et al. 
(2006), unless specified otherwise
d The enzyme levels were estimated from the intensity of the SULT band in Coomassie blue-stained polyacrylamide gels after electrophoresis 
(Meinl et al. 2006)
e Due to the inhibition of sulfoconjugation at concentrations ≥ 50 mM HMF, the data were fitted to the equation V = VMAX/(1 + KM/
[HMF] + [HMF]/KI) yielding KI = 13.2 ± 3.4 mM. The fitting curve is shown in the Supplementary Material Figure S3
f Meinl et al. (2013)
Species SULT KM (mM)
a Va,bMAX,cyt (pmol/mg/min) SULT concentration (%) V
c
MAX (pmol/mg/min) kcat/KM (s
−1 M−1)
Human 1A1 3.2 ± 0.4 778 ± 24 1.0 77,800 ± 2,400 13.7
1A2 56.5 ± 5.4 998 ± 47 1.4 71,300 ± 3,400 0.71
1A3 16.7 ± 1.8 106 ± 5 1.4f 7,570 ± 360 0.26
1B1 13.3 ± 0.3 310 ± 2 4.2 7,390 ± 40 0.31
1C2 18.8 ± 5.4 242 ± 24 1.0f 24,200 ± 2,400 0.73
Mouse 1a1 2.0 ± 0.3 2,350 ± 80 4.2 55,900 ± 1,800 15.8
1b1 9.5 ± 1.1 121 ± 5 2.0 6,030 ± 250 0.36
1d1 31.9 ± 5.7 30,000 ± 2,200 11d 273,000 ± 20,000 4.8
Rat 1a1 4.9 ± 0.7 59.5 ± 2.7 0.13 45,800 ± 2,100 5.3
1b1 15.7 ± 0.9 61.7 ± 1.4 2.5f 2,470 ± 60 0.09
1c1e 18.4 ± 4.7 391 ± 76 10d 3,910 ± 760 0.12
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prohibited its direct quantification. We tested various nucleo-
philes as trapping agents for 2-sulfoxymethylfuran, including 
adenosine, guanosine, 2′-deoxyadenosine, 2′-deoxyguano-
sine, Boc-lysine, glutathione and N-acetylcysteine. Adenosine 
was selected because it was well soluble in the incubation 
medium and formed a single reaction product with 2-sul-
foxymethylfuran. The presumed product N6-MF-A was syn-
thesized via a biomimetic approach. The mass spectrometric 
collision-induced dissociation showed the expected fragmen-
tation patterns (Fig. 2): the cleavage of the 2-methylfuran 
cation (m/z = 348.1 → 81.0), the neutral loss of the ribose 
unit (m/z = 348.1 → 216.1) and the release of the positively 
charged N6-methylated adenine (m/z = 348.1 → 148.0). The 
1H-NMR spectrum (Supplementary Material Fig. S4) cor-
roborated the expected structure of N6-MF-A to consist of the 
ribonucleoside with a single 2-methylfuran moiety attached 
to the exocyclic nitrogen of the adenine, a structural scaffold 
that has been observed previously for many 2′-deoxyadeno-
sine adducts of SULT-activated hydrocarbons (Herrmann et al. 
2012; Monien et al. 2008, 2011, 2012). For the quantification 
of N6-MF-A by UPLC-MS/MS MRM in incubation mix-
tures containing SULTs and FFA, we synthesized the isotope-
labeled reference compound [15N5]N
6-MF-A. Figure 3 shows 
the MRM chromatograms resulting from the neutral loss of 
the ribose of N6-MF-A (m/z = 348.1 → 216.1) and the cleav-
age of the methylfuran moiety (m/z = 348.1 → 81.0). As an 
additional qualifier signal, the release of the N6-methylated 
adenine (m/z = 348.1 → 148.0) was monitored, which further 
increased the specificity of the mass spectrometric detection 
(not shown). The limit of detection (signal-to-noise ratio = 4) 
of the technique was 0.8 fmol N6-MF-A per injection.
Sulfoconjugation of FFA by individual SULT forms 
from human, mouse and rat
The sulfoconjugation assay was performed under simi-
lar conditions as used for HMF, with three different 
Fig. 1  HMF sulfoconjugation by hSULT1A1 (a), mSult1a1 (b) and 
rSult1a1 (c). The rates at single HMF concentrations are mean ± SE 
of three or four measurements. Fitting of the data with the Michae-
lis–Menten model yielded values for the catalytic parameters KM and 
apparent VMAX,cyt. These were subsequently corrected for the actual 
concentrations of particular SULT forms in the cytosolic preparations 
(Table 2)
Fig. 2  Molecular structure and fragmentation pattern of N6-MF-
A observed by positive ESI MS/MS collision-induced dissocia-
tion. Principal fragmentation ions of N6-MF-A were as follows: 
m/z = 216.1 (aglycone of N6-MF-A), m/z = 81.0 (the cation of meth-
ylfuran) and m/z = 148.0 (N6-methyladenosine)
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concentrations of FFA (0.1, 1 and 10 mM). Table 3 sum-
marizes the formation rates of N6-MF-A, which were used 
as surrogate parameter for the SULT-specific capacities of 
FFA turnover. In cytosolic preparations containing human 
SULTs and 1 mM FFA, N6-MF-A was most rapidly formed 
in the presence of SULT1A1, 1C2 and 1B1. Other human 
enzymes leading to detectable levels of N6-MF-A were 
SULT1A2, 1A3, 1C3, 1E1 and 2A1. Among all mouse Sult 
forms tested, FFA sulfoconjugation by Sult1a1 and 1d1 led 
to relatively high levels of N6-MF-A, which was less effi-
ciently formed in incubations containing mSult1b1, 1e1, 
2a1 and 2a2. In rats, Sult2a3 was an efficient catalyst of 
FFA sulfoconjugation, whereas rSult1a1, 1b1, 1c1 and 2a1 
showed lower, but measurable activity.
We determined the reaction efficiency of chemically syn-
thesized 2-sulfoxymethylfuran with adenosine in the pres-
ence of cytosolic protein of native S. typhimurium TA1538 
under normal incubation conditions. In this experiment, 
about 1.5 % of the 2-sulfoxymethylfuran was converted 
into N6-MF-A (data not shown). However, the estimation 
was beset with different inaccuracies and, therefore, was 
not used to determine FFA sulfoconjugation quantitatively. 
First, the chemical syntheses of 2-sulfoxymethylfuran pro-
vide mixtures of different salts, e.g., sodium sulfate, which 
contained only 18.3 % 2-sulfoxymethylfuran in a previous 
study (Glatt et al. 2012) and only 13.2 % 2-sulfoxymethyl-
furan in the current study. Consequently, incubation mix-
tures of chemically synthesized 2-sulfoxymethylfuran with 
adenosine did not exactly match the chemical composition 
of the sulfoconjugation assay. Furthermore, the adduct for-
mation in mixtures of chemically synthesized 2-sulfoxym-
ethylfuran with adenosine may differ from that in incuba-
tions in which 2-sulfoxymethylfuran is formed slowly from 
FFA and SULTs.
The N6-MF-A formation rates of the most important 
SULT forms observed at 1 mM FFA were corrected by the 
actual SULT level of the cytosolic preparations (Table 2). 
SULT1A1 was the most efficacious catalyst of FFA sul-
foconjugation in human, mouse and rat, leading to for-
mation of 57,500, 61,700 and 24,400 fmol N6-MF-A/mg/
min, respectively (Table 3). Among the human enzymes, 
SULT1C2 was also very efficacious (45,900 fmol N6-MF-
A/mg/min). In contrast, the FFA turnover by other SULT 
forms was remarkably less effective. The rate of N6-MF-
A appearance observed in incubation mixtures containing 
hSULT1A1 was about 11- to 30-fold greater compared 
with hSULT1A2, 1A3, 1B1, 1C3 and 2A1. Mouse Sult1a1 
catalyzed FFA bioactivation about 14 times more effec-
tively compared with mSult1d1, whereas N6-MF-A was not 
detectable at 1 mM FFA in the presence of mSult1b1. In 
rats, the formation of N6-MF-A was about 6- and 71-fold 
greater in cytosolic preparations containing rSult1a1 com-
pared with those of rSult1c1 and 1b1, respectively. How-
ever, the data indicated that hydroxysteroid rSult2a3, which 
is predominantly expressed in female liver (Dunn and 
Klaassen 1998), may be the most effective catalyst of FFA 
sulfoconjugation in rats.
Discussion
Considerable species-dependent differences of SULT 
expression and substrate specificities have been found 
(Glatt 2002). For example, tamoxifen is a potent carcino-
gen in rat but not in human liver. A major phase I metab-
olite, α-hydroxytamoxifen is activated by hepatic rat 
SULT2A3 producing a DNA-reactive sulfate ester (Glatt 
et al. 1998). Further, the benzylic alcohol 2-hydroxy-
3-methylcholanthrene, a primary metabolite of the carcino-
gen 3-methylcholanthrene, was efficiently bioactivated by 
hSULT1A1 expressed in S. typhimurium, but not by the 
Fig. 3  UPLC-MS/MS MRM analysis of N6-MF-A in a cytosolic 
preparation containing hSULT1A1, FFA and adenosine. The chroma-
tograms originate from the fragmentations m/z = 348.1 → 216.1 (a) 
and m/z = 348.1 → 81.0 (b) of N6-MF-A and from the transitions 
m/z = 353.1 → 221.1 (c) and m/z = 353.1 → 81.0 (d) of the internal 
isotope-labeled standard [15N5]N
6-MF-A (7.0 fmol/injection)
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orthologues of mouse, rat and dog (Meinl et al. 2013). Par-
allel species-dependent differences may introduce incalcu-
lable uncertainties in human risk assessment of SULT-acti-
vated compounds from the results of two-year bioassays. 
The substituted furans HMF and FFA are rodent carcino-
gens present at high concentrations in the human diet. The 
carcinogenicity was proposed to originate from sulfocon-
jugation yielding reactive sulfate esters (Glatt and Sommer 
2006; Surh 1998; Surh et al. 1990) that form specific DNA 
adducts in mammalian cell culture (Monien et al. 2012) 
and mice (Monien et al. 2011). It is of utmost importance 
to know whether humans may be more (or less) suscepti-
ble to the carcinogenic effects of HMF and FFA intake than 
rodents.
Here, we studied the sulfoconjugation of the furan 
derivatives in vitro taking into account twelve human, ten 
mouse and eight rat SULT forms (Tables 1, 3). Eleven 
enzymes were selected for detailed kinetic analyses, based 
on the results of the initial screening and the expression 
levels in liver (target of HMF-induced carcinogenicity in 
the mouse), kidney (target of FFA-induced carcinogenic-
ity in the mouse) and intestine (induction of preneoplasia 
by HMF in rats and mice). In humans, SULT1A1 has a 
dominant role in the activation of many benzylic alcohols, 
a broad substrate tolerance, and is highly expressed in 
numerous tissues (Glatt et al. 2001; Glatt and Meinl 2005). 
SULT1C2 was of special interest because HMF and FFA 
were particularly mutagenic in S. typhimurium TA100-
hSULT1C2 (Glatt et al. 2012), and hSULT1B1 is present 
at high levels in colon, rectum and in other compartments 
of the gastrointestinal tract and in the liver (Teubner et al. 
2007; Wang et al. 1998), all of which are potential target 
Table 3  Rates of N6-
MF-A formation after FFA 
sulfoconjugation in cytosolic 
preparations of S. typhimurium 
TA1538 containing different 
SULT forms and adenosine as 
nucleophilic scavenger
Values are mean ± SE of 
four measurements from 
independent incubations. Only 
N6-MF-A levels exceeding the 
background signal by more than 
twofold were considered to be 
above the detection limit
a The rate of N6-MF-A 
formation at 1 mM FFA 
was corrected by the actual 
concentrations of individual 
SULT forms in the cytosolic 
preparations (compare Table 2)
b If not listed in Table 2, the 
SULT concentrations were 
reported in (Meinl et al. 2006)
Species SULT Rate (fmol N6-MF-A/mg/min)
0.1 mM FFA 1 mM FFA 10 mM FFA 1 mM FFA 
(corr.)a
Human 1A1 73.5 ± 1.1 575 ± 2 931 ± 5 57,500 ± 200
1A2 <18 34.8 ± 0.5 150 ± 4 2,480 ± 30
1A3 <18 27.3 ± 0.5 226 ± 3 1,950 ± 30
1B1 23.3 ± 0.3 211 ± 2 1,070 ± 20 5,010 ± 50
1C1 <18 <20 <44
1C2 51.3 ± 0.8 459 ± 2 2,230 ± 10 45,900 ± 200
1C3 <18 61.8 ± 0.3 248 ± 3 3,090 ± 10b
1E1 <18 <20 47.0 ± 0.9
2A1 <18 37.0 ± 0.6 386 ± 6 2,110 ± 40b
2B1a <18 <20 <44
2B1b <18 <20 <44
4A1 <18 <20 <44
Mouse 1a1 361 ± 4 2,590 ± 20 5,140 ± 60 61,700 ± 400
1b1 <18 <20 74.3 ± 1.6
1c2 <18 <20 <44
1d1 52.5 ± 1.7 468 ± 6 2,610 ± 30 4,260 ± 60
1e1 <18 49.3 ± 1.2 425 ± 3
2a1 <18 <20 154 ± 2
2a2 <18 <20 216 ± 3
2a3 <18 <20 <44
2b1b <18 <20 <44
5a1 <18 <20 <44
Rat 1a1 <18 31.8 ± 0.8 <44 24,400 ± 600
1b1 <18 34.3 ± 1.0 314 ± 4 343 ± 10
1c1 <18 97.8 ± 2.3 492 ± 13 3,910 ± 90
1c2 <18 <20 <44
2a1 <18 24.8 ± 1.4 228 ± 7
2a3 48.3 ± 1.3 461 ± 8 3,420 ± 30
2a4 <18 <20 <44
2b1 <18 <20 <44
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organs for HMF-induced carcinogenicity (National Toxi-
cology Program 2008; Svendsen et al. 2009, 524; Zhang 
et al. 1993, 83). SULT1A3 is an abundant enzyme in many 
tissues (except liver) with especially high levels in the gas-
trointestinal tract (Teubner et al. 2007).
Mouse Sults were chosen in consideration of the major 
target tissues of HMF- and FFA-mediated carcinogenic 
effects in liver (National Toxicology Program 2008) and in 
kidneys (National Toxicology Program 1999), respectively. 
Alnouti and Klaassen reported that mSult1a1 is the predom-
inant hepatic form as judged from mRNA levels. Sult1d1 is 
highly expressed in kidney and at moderate levels through-
out the gastrointestinal tract of mice, which is also rich in 
mSult1b1 (Alnouti and Klaassen 2006). Further, HMF and 
FFA produced strong mutagenic effects in mSult1a1- and 
mSult1d1-expressing TA100 strains (Glatt et al. 2012). Rat 
Sults were selected as follows. In male rats, Sult1a1 and 
1c1 are expressed at substantial levels in the liver but also in 
the kidneys (Dunn and Klaassen 1998; Honma et al. 2001). 
Rat Sult1b1 is expressed in liver and kidneys of males and 
females but also in the intestine, a reported target organ for 
the neoplastic effect of HMF (Zhang et al. 1992).
The catalytic efficiencies of HMF turnover by the 
selected SULT forms were calculated from Michaelis–
Menten constants KM and turnover numbers kcat (Table 2). 
Human SULT1A1 and the orthologous enzymes in mice 
and rats were the predominant catalysts of HMF sulfo-
conjugation. The data showed that among the other SULT 
forms only mSult1d1 was similarly effective, but required 
high substrate concentrations (KM = 31.9 ± 5.7 mM). The 
formation rates of N6-MF-A, used as a surrogate marker 
of FFA sulfoconjugation (Table 3), largely paralleled the 
ranking of HMF sulfoconjugation capacity. There were 
two notable exceptions. First, N6-MF-A was formed almost 
equally well by hSULT1C2 and hSULT1A1 in the pres-
ence of 1 mM FFA, whereas HMF sulfoconjugation was 
catalyzed about 19 times more effective by hSULT1A1 
compared with hSULT1C2. We did not further investi-
gate this difference, because hSULT1C2 may be of minor 
importance for the metabolism due to its low expression. 
The mRNA was primarily found in fetal tissues (Sakak-
ibara et al. 1998), while the hSULT1C2 protein was hith-
erto detected only in Caco-2 cells (Meinl et al. 2008). The 
second deviation between HMF and FFA sulfoconjuga-
tion was observed for mSul1d1. The catalytic efficiency of 
mSult1d1 regarding HMF sulfoconjugation was three times 
less than that observed for mSult1a1, whereas the N6-MF-
A formation rate in the presence of mSul1d1 at 1 mM FFA 
was about 14-fold lower compared with that observed for 
mSult1a1. Apart from these differences, the corrected rates 
of N6-MF-A formation indicated that, in agreement to HMF 
sulfoconjugation, hSULT1A1 and its rodent orthologues 
were the most effective catalysts of FFA turnover.
The relative importance of SULT1A1 for the turnover 
of many other substrates has been reported. For example, 
a survey of eight human SULTs identified SULT1A1 as 
the predominant enzyme for the sulfoconjugation of vari-
ous endogenous compounds, e.g., epinephrine, 2-hydrox-
yestradiol, T2 (3,5-diiodo-l-thyronine) and cholesterol, as 
well as xenobiotica, e.g., minoxidil, 4-methylphenol and 
α-zearalenol (Allali-Hassani et al. 2007). It is of note that 
the KM values of the SULT1A1 forms for the turnover of 
HMF were high compared with those of other substrates. 
Honma reported KM values of 3.0, 18 and 130 µM for the 
sulfoconjugation of p-nitrophenol, 6-hydroxymelatonin 
and dopamine by hSULT1A1, respectively (Honma et al. 
2001). Similar to HMF, a KM of 2.4 mM was determined 
for the turnover of paracetamol by hSULT1A1 (Adjei et al. 
2008). The high KM values of all SULT1A1 forms observed 
in the current study indicate a relatively weak binding affin-
ity of HMF. This is a possible reason why only 500 ppm of 
100 mg HMF/kg body weight administered to mice were 
converted to SMF (Monien et al. 2009). To our knowledge, 
KM values for the conversion of HMF by alcohol and alde-
hyde dehydrogenases have not been reported.
Due to the lability of the reactive sulfate esters, the bioac-
tivation of benzylic alcohols by individual SULT forms was 
frequently assessed by the mutagenic effect of the substrates 
in SULT-expressing S. typhimurium TA100 or TA1538 
strains (Glatt and Meinl 2004). It was found that hSULT1A1 
was most important for the sulfoconjugation of various pro-
mutagens, e.g., (±)-1′-hydroxymethyleugenol (Herrmann 
et al. 2012), nitrofen (Glatt and Meinl 2004), 1-hydroxym-
ethylpyrene (Meinl et al. 2002) and 2-hydroxy-3-methyl-
cholanthrene (Meinl et al. 2013), whereas other SULT forms 
of human origin or from other species contributed little or 
nothing at all to the mutagenic activity of these compounds. 
The results presented in this study were in agreement with 
a previous report about the mutagenicity of HMF and FFA 
in S. typhimurium TA100 strains expressing different SULT 
forms. Mutagenic effects of HMF, albeit small, were detect-
able in those strains that expressed hSULT1A1, 1A3 and 
1C2 as well as mSult1a1 and 1d1. The highest mutagenic-
ity of FFA was observed in bacteria expressing hSULT1A1, 
1C2 and mSult1a1 (Glatt et al. 2012).
Besides the species-dependent efficiency of SULT1A1-
mediated bioactivation, also the expression levels of the 
enzyme may influence the carcinogenic risk of HMF and 
FFA in each of the organisms. Despite the principal role 
of SULT1A1 in the metabolism of many endogenous and 
exogenous compounds, the knowledge about its expres-
sion in different organisms is limited. In humans, SULT1A1 
is found in many tissues at high levels, e.g., in liver, lung, 
brain, throughout the gastrointestinal tract and in kidneys 
(Glatt 2002; Meinl et al. 2006; Riches et al. 2009; Teub-
ner et al. 2007). The SULT1A1 levels found in human liver 
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(420–4,900 ng/mg cytosolic protein, n = 28) (Riches et al. 
2009) and the ileum (990–1,600 ng/mg cytosolic protein, 
n = 4) (Teubner et al. 2007) were considerably higher com-
pared with those in kidneys (30–270 ng/mg cytosolic pro-
tein, n = 10) (Meinl et al. 2006; Riches et al. 2009). Little 
data of Sult1a1 expression on the protein level are available 
for mice and rats. Honma et al. reported hepatic Sult1a1 
amounts of 2,300 ± 100 ng/mg cytosolic protein (n = 3) 
and 4,400 ± 200 ng/mg cytosolic protein (n = 3) in male 
and female mice, respectively, and 9,100 ± 200 ng/mg cyto-
solic protein (n = 3) and 6,300 ± 500 ng/mg cytosolic pro-
tein (n = 3) in liver of male and female rats, respectively. 
Judged from concentrations of mRNA, the highest amounts 
of mSult1a1 were expressed in liver, lung and large intestine, 
whereas the Sult1a1 expression in the small intestine of mice 
was negligible as judged from the mRNA levels (Alnouti and 
Klaassen 2006). In rats, mRNA of Sult1a1 is expressed in 
many tissues, albeit at levels that are minute in comparison 
with the liver (Dunn and Klaassen 1998). Taken together, 
the current knowledge about SULT1A1 expression in dif-
ferent species does not allow assuming a species-dependent 
carcinogenic risk of SULT1A1-activated compounds. How-
ever, HMF and FFA were more effectively bioactivated 
by mSult1a1 than by rSult1a1. This may explain why car-
cinogenic effects of HMF and FFA were observed in mice 
and not in rats (National Toxicology Program 1999, 2008). 
Our data further indicate that hSULT1A1 conjugates HMF 
and FFA as efficient as mSult1a1. However, looking only 
at SULTs would present a simplification. The concentration 
of the reactive sulfate esters in particular tissues and species 
may also be influenced by various other parameters, such as 
detoxification of the precursors and the sulfate esters, tis-
sue-specific directed export and import of the sulfate esters, 
transport via the blood stream and excretion.
In summary, it becomes increasingly clear that HMF 
and FFA are sulfoconjugated not only in mice (Monien 
et al. 2009, 2011) but also in the human body. The char-
acterization of HMF and FFA sulfoconjugation capacity 
of individual human, mouse and rat SULT forms showed 
that hSULT1A1 and the orthologous enzymes in mice and 
rats catalyzed the bioactivation of the substituted furans 
most efficiently compared with all other SULTs. Human 
SULT1A1 was about as effective as Sult1a1 of mice, the 
principal species in which carcinogenic effects of HMF 
(liver) and FFA (kidney) were observed. This raises concern 
because hSULT1A1 is ubiquitously expressed at high levels 
in several tissues, e.g., liver, lung, gastrointestinal tract and 
kidney (Glatt 2002; Meinl et al. 2006; Teubner et al. 2007).
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